Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Greco

Showing results (291-300 of 313) with videos related to

Pageof 32
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatinF A Greco, J B Erland, L H Morrissey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research networkA A Meluch, F A Greco, H A Burris, et al.
Cancer Treatment Reports|February 1, 1983
Phase II evaluation of spirogermanium in advanced ovarian carcinomaD E Brenner, H W Jones, N B Rosenshein, et al.
Bone Marrow Transplantation|December 24, 1997
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinomaC H Weaver, F A Greco, J D Hainsworth, et al.
British Journal of Haematology|March 6, 1998
Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastimC H Weaver, R Birch, F A Greco, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocolC R Nichols, S D Williams, P J Loehrer, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.
Pageof 32

Showing results (291-300 of 313) with videos related to

Sort By:
Pageof 32
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatinF A Greco, J B Erland, L H Morrissey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research networkA A Meluch, F A Greco, H A Burris, et al.
Cancer Treatment Reports|February 1, 1983
Phase II evaluation of spirogermanium in advanced ovarian carcinomaD E Brenner, H W Jones, N B Rosenshein, et al.
Bone Marrow Transplantation|December 24, 1997
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinomaC H Weaver, F A Greco, J D Hainsworth, et al.
British Journal of Haematology|March 6, 1998
Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastimC H Weaver, R Birch, F A Greco, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocolC R Nichols, S D Williams, P J Loehrer, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2001
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trialJ D Hainsworth, H A Burris, D A Yardley, et al.
Pageof 32